Levothyroxine attenuates behavioral impairment and improves oxidative stress and histological alteration 3-nitropropionic acid induced experimental Huntington's disease in rats

被引:1
|
作者
Badini, Fereshteh [1 ]
Bayrami, Abolfazl [1 ]
Mirshekar, Mohammad Ali [2 ,3 ,6 ]
Shahraki, Samira [3 ,4 ]
Fanaei, Hamed [3 ,5 ]
机构
[1] Univ Mohaghegh Ardabili, Fac Sci, Dept Biol, Ardabili, Iran
[2] Zahedan Univ Med Sci, Clin Immunol Res Ctr, Sch Med, Zahedan, Iran
[3] Zahedan Univ Med Sci, Sch Med, Dept Physiol, Zahedan, Iran
[4] Zahedan Univ Med Sci, Cellular & Mol Res Ctr, Sch Med, Zahedan, Iran
[5] Zahedan Univ Med Sci, Pregnancy Hlth Res Ctr, Zahedan, Iran
[6] Zahedan Univ Med Sci, Fac Med, Dept Physiol, Zahedan, Iran
关键词
Huntington's disease; 3-Nitropropionic acid; Levothyroxine; Oxidative stress; Motor dysfunction; MITOCHONDRIAL TOXIN; MODEL; PREVENTS;
D O I
10.1016/j.bbr.2024.114864
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Huntington's disease (HD) is a neurodegenerative disorder characterized by degeneration of the striatum; it results in oxidative stress and motor deficits. Thyroid hormones regulate oxidative metabolism. In the present study, we evaluated the effect of administration of levothyroxine (LT -4) on neurobehavioral, oxidative stress, and histological changes in a rat model of HD. Forty-eight Wistar male rats were divided into the following six groups (n = 8): Group 1 (control) received physiological saline intraperitoneally (ip). Groups 2 and 3 received L -T4,30 and L -T4100 (mu g/kg, ip, respectively) daily for 7 days. Group 4 (HD) received 3-nitropropionic acid (3 -NP) (25 mg/kg, ip) daily for 7 days. Groups 5 and 6 received L -T4,30 and L -T4100 (mu g/kg, ip, respectively) 30 min after 3NP (25 mg/kg, ip) injection for the same duration. On the 8th day, behavioral parameters were evaluated with the Rotarod, Narrow beam walk, and Limb withdrawal tests. Oxidative markers such as Malondialdehyde (MDA) and Glutathione (GSH) levels and Superoxide dismutase (SOD) activity, in striatum tissue were measured. Moreover, striatum tissues were analyzed by Hematoxylin-eosin staining for histological alterations. We found that 3 -NP administration caused motor incoordination and induced oxidative stress increased but reduced free radical scavenging. Also, increased amounts of lipid peroxides caused striatal damage as shown by histopathological evaluation. Administration of L -T4 led to increased falling time in the Rotarod, but reduced the time taken in Narrow beam walking and Limb withdrawal test. Furthermore, L -T4 increased antioxidant activity, decreased lipid peroxidation and ameliorated 3 -NP -induced degeneration in neurons.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Piroxicam attenuates 3-nitropropionic acid-induced brain oxidative stress and behavioral alteration in mice
    Jadiswami, C.
    Megha, H. M.
    Dhadde, Shivsharan B.
    Durg, Sharanbasappa
    Potadar, Pandharinath P.
    Thippeswamy, B. S.
    Veerapur, V. P.
    TOXICOLOGY MECHANISMS AND METHODS, 2014, 24 (09) : 672 - 678
  • [2] MODEL OF HUNTINGTON'S DISEASE INDUCED WITH 3-NITROPROPIONIC ACID
    Tunez, I.
    Santamaria, A.
    REVISTA DE NEUROLOGIA, 2009, 48 (08) : 430 - 434
  • [3] Cyclooxygenase inhibitors attenuate 3-nitropropionic acid-induced oxidative stress and memory impairment in an animal model of Huntington's disease
    Pattipati, SN
    Kumar, P
    Kumar, A
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76
  • [4] Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease
    Yan Gao
    Shi-feng Chu
    Jian-ping Li
    Zhao Zhang
    Jia-qing Yan
    Zhi-lin Wen
    Cong-yuan Xia
    Zheng Mou
    Zhen-zhen Wang
    Wen-bin He
    Xiao-feng Guo
    Gui-ning Wei
    Nai-hong Chen
    Acta Pharmacologica Sinica, 2015, 36 : 311 - 322
  • [5] Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease
    Gao, Yan
    Chu, Shi-feng
    Li, Jian-ping
    Zhang, Zhao
    Yan, Jia-qing
    Wen, Zhi-lin
    Xia, Cong-yuan
    Mou, Zheng
    Wang, Zhen-zhen
    He, Wen-bin
    Guo, Xiao-feng
    Wei, Gui-ning
    Chen, Nai-hong
    ACTA PHARMACOLOGICA SINICA, 2015, 36 (03) : 311 - 322
  • [6] Effect of embelin against 3-nitropropionic acid-induced Huntington's disease in rats
    Dhadde, Shivsharan B.
    Nagakannan, P.
    Roopesh, Marulasiddeshwara
    Kumar, S. R. Anand
    Thippeswamy, B. S.
    Veerapur, Veeresh P.
    Badami, S.
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 77 : 52 - 58
  • [7] Beneficial effect of rice bran extract against 3-nitropropionic acid induced experimental Huntington's disease in rats
    Kaur, Navneet
    Jamwal, Sumit
    Deshmukh, Rahul
    Gauttam, Vinod
    Kumar, Puneet
    TOXICOLOGY REPORTS, 2015, 2 : 1222 - 1232
  • [8] Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats
    Tariq, M
    Khan, HA
    Elfaki, I
    Al Deeb, S
    Al Moutaery, K
    BRAIN RESEARCH BULLETIN, 2005, 67 (1-2) : 161 - 168
  • [9] Agmatine mitigates behavioral abnormalities and neurochemical dysregulation associated with 3-Nitropropionic acid-induced Huntington ' s disease in rats
    Katariya, Raj
    Mishra, Kartikey
    Sammeta, Shivkumar
    Umekar, Milind
    Kotagale, Nandkishor
    Taksande, Brijesh
    NEUROTOXICOLOGY, 2024, 102 : 12 - 28
  • [10] Ellagic acid prevents 3-nitropropionic acid induced symptoms of Huntington’s disease
    Priya Sharma
    Manish Kumar
    Nitin Bansal
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2021, 394 : 1917 - 1928